Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masaru Mimura

Showing results (321-330 of 679) with videos related to

Pageof 68
Sort By:
Scientific Reports|May 11, 2019
Diet quality and depression risk in a Japanese population: the Japan Public Health Center (JPHC)-based Prospective StudyRyo Okubo, Yutaka J Matsuoka, Norie Sawada, et al.
Journal of Affective Disorders|December 23, 2018
Impact of subjective vs. objective remission status on subjective cognitive impairments in depressionKyosuke Sawada, Kazunari Yoshida, Chisa Ozawa, et al.
Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology|June 15, 2007
Impairment of decision-making cognition in a case of frontotemporal lobar degeneration (FTLD) presenting with pathologic gambling and hoarding as the initial symptomsShutaro Nakaaki, Yoshie Murata, Junko Sato, et al.
Neuropsychopharmacology Reports|September 19, 2019
Acceptability of escitalopram versus duloxetine in outpatients with depression who did not respond to initial second-generation antidepressants: Study protocol for a randomized, parallel-group, non-inferiority trialYuma Yokoi, Atsuo Nakagawa, Naoki Yoshimura, et al.
Psychiatry and Clinical Neurosciences|March 16, 2022
Publication Rate in English of Abstracts Presented at the Annual Meeting of the Japanese Society of Psychiatry and NeurologyKazunari Yoshida, Sho Moriguchi, Masahide Koda, et al.
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|April 26, 2019
Factor structure of the Japanese version of the Quality of Life in Alzheimer's Disease Scale (QOL-AD)Takahiro Yamada, Shutaro Nakaaki, Junko Sato, et al.
Journal of Personalized Medicine|June 2, 2021
TMS-EEG Research to Elucidate the Pathophysiological Neural Bases in Patients with Schizophrenia: A Systematic ReviewXuemei Li, Shiori Honda, Shinichiro Nakajima, et al.
Scientific Reports|August 14, 2023
Metabolites for monitoring symptoms and predicting remission in patients with depression who received electroconvulsive therapy: a pilot studyTakahito Uchida, Yuki Sugiura, Eiji Sugiyama, et al.
Journal of Affective Disorders|July 27, 2013
Trajectories of individual symptoms in remitters versus non-remitters with depressionHitoshi Sakurai, Hiroyuki Uchida, Takayuki Abe, et al.
Scientific Reports|February 18, 2021
Plasma phospholipid n-3 polyunsaturated fatty acids and major depressive disorder in Japanese elderly: the Japan Public Health Center-based Prospective StudyKei Hamazaki, Yutaka J Matsuoka, Taiki Yamaji, et al.
Pageof 68

Showing results (321-330 of 679) with videos related to

Sort By:
Pageof 68
Scientific Reports|May 11, 2019
Diet quality and depression risk in a Japanese population: the Japan Public Health Center (JPHC)-based Prospective StudyRyo Okubo, Yutaka J Matsuoka, Norie Sawada, et al.
Journal of Affective Disorders|December 23, 2018
Impact of subjective vs. objective remission status on subjective cognitive impairments in depressionKyosuke Sawada, Kazunari Yoshida, Chisa Ozawa, et al.
Cognitive and Behavioral Neurology : Official Journal of the Society for Behavioral and Cognitive Neurology|June 15, 2007
Impairment of decision-making cognition in a case of frontotemporal lobar degeneration (FTLD) presenting with pathologic gambling and hoarding as the initial symptomsShutaro Nakaaki, Yoshie Murata, Junko Sato, et al.
Neuropsychopharmacology Reports|September 19, 2019
Acceptability of escitalopram versus duloxetine in outpatients with depression who did not respond to initial second-generation antidepressants: Study protocol for a randomized, parallel-group, non-inferiority trialYuma Yokoi, Atsuo Nakagawa, Naoki Yoshimura, et al.
Psychiatry and Clinical Neurosciences|March 16, 2022
Publication Rate in English of Abstracts Presented at the Annual Meeting of the Japanese Society of Psychiatry and NeurologyKazunari Yoshida, Sho Moriguchi, Masahide Koda, et al.
Psychogeriatrics : the Official Journal of the Japanese Psychogeriatric Society|April 26, 2019
Factor structure of the Japanese version of the Quality of Life in Alzheimer's Disease Scale (QOL-AD)Takahiro Yamada, Shutaro Nakaaki, Junko Sato, et al.
Journal of Personalized Medicine|June 2, 2021
TMS-EEG Research to Elucidate the Pathophysiological Neural Bases in Patients with Schizophrenia: A Systematic ReviewXuemei Li, Shiori Honda, Shinichiro Nakajima, et al.
Scientific Reports|August 14, 2023
Metabolites for monitoring symptoms and predicting remission in patients with depression who received electroconvulsive therapy: a pilot studyTakahito Uchida, Yuki Sugiura, Eiji Sugiyama, et al.
Journal of Affective Disorders|July 27, 2013
Trajectories of individual symptoms in remitters versus non-remitters with depressionHitoshi Sakurai, Hiroyuki Uchida, Takayuki Abe, et al.
Scientific Reports|February 18, 2021
Plasma phospholipid n-3 polyunsaturated fatty acids and major depressive disorder in Japanese elderly: the Japan Public Health Center-based Prospective StudyKei Hamazaki, Yutaka J Matsuoka, Taiki Yamaji, et al.
Pageof 68